Infigratinib phosphate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for infigratinib phosphate and what is the scope of patent protection?
Infigratinib phosphate
is the generic ingredient in one branded drug marketed by Helsinn Hlthcare and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Infigratinib phosphate has one hundred and thirty-five patent family members in forty countries.
Summary for infigratinib phosphate
International Patents: | 135 |
US Patents: | 4 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Clinical Trials: | 1 |
Patent Applications: | 26 |
DailyMed Link: | infigratinib phosphate at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for infigratinib phosphate
Generic Entry Date for infigratinib phosphate*:
Constraining patent/regulatory exclusivity:
Dosage:
CAPSULE;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for infigratinib phosphate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Institute (NCI) | Phase 2 |
Emory University | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for infigratinib phosphate
US Patents and Regulatory Information for infigratinib phosphate
International Patents for infigratinib phosphate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Malaysia | 194303 | PHARMACEUTICAL DOSAGE FORMS | ⤷ Try a Trial |
European Patent Office | 2418205 | Dérivés d'urée de pyrimidine en tant qu'inhibiteurs de kinase (Pyrimidine urea derivatives as kinase inhibitors) | ⤷ Try a Trial |
Morocco | 28695 | DERIVES PYRIMIDINES UREE EN TANT QU'INHIBITEURS DE KINASE | ⤷ Try a Trial |
South Africa | 201203612 | CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXY-PHENYL)-1-{6-[4[(4-ETHYL-PIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA AND SALTS THEREOF | ⤷ Try a Trial |
China | 103121973 | Pyrimidine urea derivatives as kinase inhibitors | ⤷ Try a Trial |
Jordan | 3061 | صور بلورية من 3- ( 2، 6- ثانى كلورو - 3، 5- ثانى ميثوكسى فينيل) - 1- { 6- [ 4- (4- ايثيل - بيبرازين - 1- يل) - فينيل أمينو ] - بيريميدين - 4- يل } - 1- ميثيل - يوريا وأملاح منها (CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYL-PIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA AND SALTS THEREOF) | ⤷ Try a Trial |
South Korea | 101787784 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |